Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Aswan University Hospital

Status: Unknown

Conditions: Infertility, Female

Treatments: Drug: lidocaine patch; Drug: Sham patch

Study type: Interventional

Funder types: Other

Identifiers

NCT04518202

aswu/296/3/19

Details and patient eligibility

About

To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Full description

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes.

Enrollment: 200 estimated patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with an indication for office hysteroscopy

Exclusion criteria

• patient refuse to participant
• contraindication for lidocaine patch

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

200 participants in 2 patient groups, including a placebo group

lidocaine patch

Experimental group

Description:

5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.

Treatment:

Drug: lidocaine patch

Sham patch

Placebo Comparator group

Description:

Sham patch applied at 6 hours before the scheduled office hysteroscopy.

Treatment:

Drug: Sham patch